Skip to main content

Advertisement

Table 3 Clinical information of rectal cancer patients used in this study

From: ¹H NMR-based metabolic profiling of human rectal cancer tissue

  Rectal cancer patients Normal controls
Number 127 43
Age (median,range) 55 28-86 56 35-85
Male/female ration 69/58 16/27
Histology Adenocarcinoma(127)
Pathologic grade  
PD 36  
MD 80  
WD 7  
NA 4  
Cancer stage/Duke  
I/A(35) T1N0M0(10)  
  T2N0M0(25)  
II/B(37) T3N0M0(37)  
III/C(37) T2N1aM0(3)  
  T2N2aM0(2)  
  T3N1aM0(16)  
  T3N1bM0(8)  
  T3N2aM0(4)  
  T3N2bM0(4)  
IV/D(18) T3N0M1a(1)  
  T3N1aM1a(1)  
  T3N1bM1a(5)  
  T3N2aM1a(5)  
  T3N2bM1a(5)  
  T4aN2bM1a(1)  
Metastatic site  
I 35(0)  
II 37(0)  
III 37(lymph node)  
IV 18(liver)  
  1. PD poorly differentiated.
  2. MD moderately differentiated.
  3. WD well-differentiated.
  4. NA not applicable.